Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             36 results found
no title author magazine year volume issue page(s) type
1 A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer Brown, E.R.

19 7 p. 1340-1346
article
2 Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK Borner, M.

19 7 p. 1288-1292
article
3 Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease Prasad, K.N.

19 7 p. 1299-1303
article
4 A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992) Theodore, C.

19 7 p. 1304-1307
article
5 Breast lymphoma Avilés, A.

19 7 p. 1360
article
6 Cancer survivorship: a challenge for the European oncologists Simonelli, C.

19 7 p. 1216-1217
article
7 Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma Troch, M.

19 7 p. 1336-1339
article
8 Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma Mantovani, G.

19 7 p. 1355
article
9 Coincidential successful treatment of Jessner–Kanof disease with chemotherapy Ardavanis, A.

19 7 p. 1360-1361
article
10 Comment on: ‘Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome’ Errante, D.

19 7 p. 1359-1360
article
11 Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer Mahner, S.

19 7 p. 1249-1254
article
12 Defining prognosis for women with breast cancer and CNS metastases by HER2 status Dawood, S.

19 7 p. 1242-1248
article
13 Disambiguating the bisphosphonates Van den Wyngaert, T.

19 7 p. 1357-1359
article
14 Editorial Board
19 7 p. ii-iii
article
15 Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression Psyrri, A.

19 7 p. 1271-1277
article
16 Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma Arcaini, L.

19 7 p. 1331-1335
article
17 Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients Braconi, C.

19 7 p. 1293-1298
article
18 Insulin receptor substrate protein 53 (IRSp53) as a binding partner of antimetastasis molecule NESH, a member of Abelson interactor protein family Matsuda, S.

19 7 p. 1356-1357
article
19 Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies Martin, P.

19 7 p. 1327-1330
article
20 In this issue
19 7 p. 1211
article
21 Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? Suzuki, S.

19 7 p. 1284-1287
article
22 Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma Sirohi, B.

19 7 p. 1312-1319
article
23 Pancreatic cancer—is the wall crumbling? Chua, Y.J.

19 7 p. 1224-1230
article
24 Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy Diéras, V.

19 7 p. 1255-1260
article
25 Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Regan, M.M.

19 7 p. 1231-1241
article
26 p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes Bidard, F.-C.

19 7 p. 1261-1265
article
27 Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study von Moos, R.

19 7 p. 1266-1270
article
28 Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias Capdeville, R.

19 7 p. 1320-1326
article
29 Response of malignant thymoma to erlotinib Christodoulou, C.

19 7 p. 1361-1362
article
30 Src as a potential therapeutic target in non-small-cell lung cancer Giaccone, G.

19 7 p. 1219-1223
article
31 Stopping a trial early in oncology: for patients or for industry? Trotta, F.

19 7 p. 1347-1353
article
32 Table of Contents
19 7 p. iv-v
article
33 The difficult decision-making process for using or not using adjuvant chemotherapy in premenopausal endocrine-responsive breast cancer patients Del Mastro, L.

19 7 p. 1213-1215
article
34 The postchemotherapy PSA surge syndrome Thuret, R.

19 7 p. 1308-1311
article
35 The role of DNA ploidy in postoperative management of stage I endometrial cancer Mangili, G.

19 7 p. 1278-1283
article
36 Volume 18, Supplement 3, A global comparison regarding patient access to cancer drugs
19 7 p. 1363
article
                             36 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands